Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
What's in a name? A historical perspective on the change of the name of our specialty from Female Pelvic Medicine and Reconstructive Surgery (FPMRS) to Urogynecology and Reconstructive Pelvic Surgery (URPS).
Vasavada S, Ginsberg D, Kobashi K, Clemens JQ, Wein A, Cameron A. Vasavada S, et al. Among authors: kobashi k. Neurourol Urodyn. 2024 May 30. doi: 10.1002/nau.25512. Online ahead of print. Neurourol Urodyn. 2024. PMID: 38813834 No abstract available.
Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.
Uchinami Y, Yasuda K, Minatogawa H, Dekura Y, Nishikawa N, Kinoshita R, Nishioka K, Katoh N, Mori T, Otsuka M, Miyamoto N, Suzuki R, Kobashi K, Shimizu Y, Taguchi J, Tsushima N, Kano S, Homma A, Aoyama H. Uchinami Y, et al. Among authors: kobashi k. Radiat Oncol J. 2024 Mar;42(1):74-82. doi: 10.3857/roj.2023.00374. Epub 2024 Mar 18. Radiat Oncol J. 2024. PMID: 38549386 Free PMC article.
Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity-modulated proton therapy with robust optimization.
Yoshimura T, Yamada R, Kinoshita R, Matsuura T, Kanehira T, Tamura H, Nishioka K, Yasuda K, Taguchi H, Katoh N, Kobashi K, Hashimoto T, Aoyama H. Yoshimura T, et al. Among authors: kobashi k. J Radiat Res. 2024 May 23;65(3):369-378. doi: 10.1093/jrr/rrae008. J Radiat Res. 2024. PMID: 38499489 Free PMC article.
Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101).
Tsuji K, Mizugaki H, Yokoo K, Kobayashi M, Kawashima Y, Kimura N, Yokouchi H, Kikuchi H, Sumi T, Kawai Y, Kobashi K, Morita R, Ito K, Kitamura Y, Minemura H, Nakamura K, Aso M, Honjo O, Tanaka H, Takashina T, Tsurumi K, Sugisaka J, Tsukita Y, Konno S, Oizumi S. Tsuji K, et al. Among authors: kobashi k. Cancer Sci. 2024 Apr;115(4):1273-1282. doi: 10.1111/cas.16094. Epub 2024 Jan 29. Cancer Sci. 2024. PMID: 38287788 Free PMC article.
Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan.
Yasuda K, Uchinami Y, Kano S, Taguchi J, Kawakita D, Kitayama M, Nishioka K, Mori T, Koizumi F, Fujii Y, Shimizu Y, Kobashi K, Yoshimoto S, Nibu KI, Homma A, Aoyama H. Yasuda K, et al. Among authors: kobashi k. Int J Clin Oncol. 2024 Mar;29(3):241-247. doi: 10.1007/s10147-023-02450-7. Epub 2023 Dec 29. Int J Clin Oncol. 2024. PMID: 38155239
Daily fraction dose-adjusted radiotherapy policy to avoid prolonging the overall treatment time for early glottic squamous cell carcinoma: a single-institutional retrospective study.
Dekura Y, Yasuda K, Minatogawa H, Uchinami Y, Tsushima N, Suzuki T, Kano S, Mori T, Nishioka K, Kobashi K, Katoh N, Homma A, Aoyama H. Dekura Y, et al. Among authors: kobashi k. J Radiat Res. 2024 Jan 19;65(1):63-70. doi: 10.1093/jrr/rrad080. J Radiat Res. 2024. PMID: 37952082 Free PMC article.
393 results